A5038656960- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Cardiac Structural Anomalies and Repair
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Arrest and Resuscitation
- Cerebrovascular and Carotid Artery Diseases
- Atrial Fibrillation Management and Outcomes
- Pulmonary Hypertension Research and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
Universität Ulm
2021-2025
University Hospital Ulm
2023-2024
The development of transcatheter tricuspid edge-to-edge repair for regurgitation is a therapeutic milestone but specific periprocedural risk assessment tool lacking. TRI-SCORE has recently been introduced as dedicated score valve surgery.This study analyzes the predictive performance following repair.180 patients who underwent at Ulm University Hospital were consecutively included and stratified into three groups. was assessed throughout follow-up period 30 days up to 1 year.All had severe...
Background: Transcatheter tricuspid edge-to-edge repair (T-TEER) is widely used to treat atrial (AFTR) and ventricular (VFTR) functional regurgitation (FTR). Methods: The outcome of 136 patients treated with T-TEER for severe AFTR or VFTR was analyzed using a composite endpoint all-cause death rehospitalization decompensated heart failure. defined as TR in the context left ejection fraction ≥50%, right fractional area change (RVFAC) ≥ 35% sPAP ≤ 50 mmHg. Results: Patients (N = 109) 27,...
Zusammenfassung Erkrankungen der Mitralklappe sind im klinisch-kardiologischen Alltag allgegenwärtig. Versagen medikamentöse Therapien, so erfolgt oft eine chirurgische oder interventionelle Behandlung. Zwar die heutigen technischen Möglichkeiten vielfältig, dennoch ist ein beträchtlicher Anteil Patienten Verlauf von einer erneuten relevanten Klappendysfunktion betroffen. Hier kann erneuter Reparaturversuch erwogen werden, wobei insbesondere bei voroperierten stark erhöhtes perioperatives...
Abstract Background Transcatheter edge-to-edge mitral valve repair (M-TEER) is often performed in general anesthesia, and postprocedural monitoring usually warranted on an intensive or intermediate care unit (ICU/IMC). We evaluated the implications of a dedicated (VU) instead ICU/IMC for after M-TEER. Methods results In total, 624 patients were retrospectively analyzed. A total 312 primarily transferred to either ICU IMC following M-TEER, scheduled VU absence indications treatment. Hospital...
(1) Objective: We aimed to assess whether the candidate profile, long-term outcomes and predictors for mortality after transcatheter edge-to-edge mitral valve repair (M-TEER) have changed over last decade; (2) Methods: Long-term follow-up data (median time of 1202 days) including mortality, MACCE functional status were available 677 consecutive patients enrolled in prospective MiTra Ulm registry from January 2010 April 2019. The initial 340 treated our institution before 2016 compared with...
Therapeutic options for patients with heart failure preserved ejection fraction (HFpEF) are sparse. Mitral regurgitation (MR) is a common feature of HFpEF and worsens symptoms prognosis. Our study examines the outcome left ventricular (LVEF) elevated atrial (LAP) or filling pressures (LVEDP), indicative HFpEF, after undergoing percutaneous edge-to-edge mitral valve repair (pMVR) moderate-severe MR.Two hundred eleven LVEF (>50%), who underwent pMVR, were dichotomized by LAP (< / ≥15 mmHg)...
Abstract Background Mitral transcatheter edge-to-edge repair (M-TEER) is an established treatment for functional mitral regurgitation (FMR) associated with a risk of creating iatrogenic stenosis. Objectives To investigate the impact P10 and its larger spacer compared to narrower Ace smaller on reduction valve orifice area (MVOA) during M-TEER. Methods Consecutive patients undergoing M-TEER severe FMR were screened retrospectively. Patients single PASCAL device implantation within central...
Modified balloon (MB) treatment in severely calcified coronary artery lesions is an established technique. However, some require Rotablation (RA) as bailout strategy.
Background Several studies have demonstrated an association between tricuspid regurgitation (TR) and organ dysfunction including hepatic renal insufficiency. Improvement of liver function following transcatheter edge-to-edge repair (T-TEER) has already been linked to reduction venous congestion due TR reduction. This study analyzes whether TR-reduction using T-TEER is also associated with improved function. Methods results The TRIC-ULM registry includes 92 selected patients undergoing March...
ABSTRACT Background Concomitant right ventricular (RV) failure and tricuspid regurgitation (TR) are common comorbidities in patients undergoing mitral valve transcatheter edge‐to‐edge repair (M‐TEER) associated with worse prognosis. Improvement of TR after M‐TEER occurs frequently, however determinants this course poorly understood. This study aimed to analyze serum biomarkers that differentially regulated identify predictive the M‐TEER. Methods Results Biomarker expression was analyzed 242...
Abstract Aims Prevalence of mitral regurgitation (MR) and comorbidity burden rise with age. Mitral valve transcatheter edge‐to‐edge repair (M‐TEER) is increasingly performed in elderly patients, but only limited data are available for this specific subgroup. In study, outcomes octogenarians nonagenarians undergoing M‐TEER were analysed using a large real‐world dataset. Methods This retrospective study included consecutive patients at the Ulm University Heart Center between January 2010...
To evaluate the impact of tricuspid regurgitation (TR) on echocardiographic and functional outcome after mitral valve transcatheter edge-to-edge-repair (M-TEER).A total 740 patients underwent M-TEER at our center from 2010 to 2021. Patients were analyzed according severity concomitant TR time procedure: low-grade (grade ≤I [trace-mild], 279 [37.7%]), moderate II, 170 [23.0%]) high-grade III-V [severe-torrential], 291 [39.3%]). with had higher morbidity. Procedural success was achieved...
Background: Improvement in concomitant tricuspid regurgitation (TR) after mitral valve transcatheter edge-to-edge repair (M-TEER) for (MR) occurs frequently; however factors determining the post-procedural course of TR are not well understood. We investigated parameters associated with improvement M-TEER. Methods and Results: A total 300 patients were consecutively included this retrospective analysis. MR severity as heart chamber metrics assessed before procedure at follow-up. Device...